Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure

Nature Reviews Cardiology

Volumn 12, Issue 8, 2015, Pages 488-497

  Greco, Carolina M ^a   Condorelli, Gianluigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOSINE; HISTONE; LONG UNTRANSLATED RNA; MICRORNA; UNTRANSLATED RNA; CARDIOTONIC AGENT; CHROMATIN; DNA;

CHROMATIN; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ACETYLATION; CARDIOMEGALY; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENETIC EPIGENESIS; GENETICS; METABOLISM; METHYLATION;

ACETYLATION; CARDIOMEGALY; CARDIOTONIC AGENTS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; HEART FAILURE; HISTONES; HUMANS; METHYLATION; MICRORNAS; RNA, UNTRANSLATED;

EID: 84938203151     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2015.71     Document Type: Review

References (116)

1. Lompre, A. M., et al. Myosin isoenzyme redistribution in chronic heart overload. Nature 282, 105-107 (1979
2. Izumo, S., Nadal-Ginard, B., & Mahdavi, V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl Acad. Sci. USA 85, 339-343 (1988
3. Hunter, J. J., & Chien, K. R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276-1283 (1999
4. Bernstein, B. E., Meissner, A., & Lander, E. S. The mammalian epigenome. Cell 128, 669-681 (2007
5. Wu, J. I., Lessard, J., & Crabtree, G. R. Understanding the words of chromatin regulation. Cell 136, 200-206 (2009
6. Stein, R., Gruenbaum, Y., Pollack, Y., Razin, A., & Cedar, H. Clonal inheritance of the pattern of DNA methylation in mouse cells. Proc. Natl Acad. Sci. USA 79, 61-65 (1982
7. Smith, Z. D., & Meissner, A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204-220 (2013
8. Wu, H., & Zhang, Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156, 45-68 (2014
9. Reik, W., Dean, W., & Walter, J. Epigenetic reprogramming in mammalian development. Science 293, 1089-1093 (2001
10. Okano, M., Bell, D. W., Haber, D. A., & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999
11. Tahiliani, M., et al Conversion of 5 methylcytosine to 5 hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009
12. Hendrich, B., & Tweedie, S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 19, 269-277 (2003
13. Movassagh, M., et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 124, 2411-2422 (2011
14. Haider, S., et al. The landscape of DNA repeat elements in human heart failure. Genome Biol. 13, R90 (2012
15. Haas, J., et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol. Med. 5, 413-429 (2013
16. Gilsbach, R., et al. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. Nat. Commun. 5, 5288 (2014
17. Ziller, M. J., et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477-481 (2013
18. Jin, S. G., Kadam, S., & Pfeifer, G. P. Examination of the specificity of DNA methylation profiling techniques towards 5 methylcytosine and 5 hydroxymethylcytosine. Nucleic Acids Res. 38, e125 (2010
19. Wang, X., & Hayes, J. J. Acetylation mimics within individual core histone tail domains indicate distinct roles in regulating the stability of higher-order chromatin structure. Mol. Cell. Biol. 28, 227-236 (2008
20. Hodawadekar, S. C., & Marmorstein, R. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene 26, 5528-5540 (2007
21. Yao, T P., et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372 (1998
22. Shikama, N., et al. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 22, 5175-5185 (2003
23. Wei, J Q., et al. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934-946 (2008
24. Yanazume, T., et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell. Biol. 23, 3593-3606 (2003
25. Morimoto, T., et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118, 868-878 (2008
26. Zhang, C. L., et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488 (2002
27. Chang, S., et al. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24, 8467-8476 (2004
28. Ago, T., et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978-993 (2008
29. Hohl, M., et al. HDAC4 controls histone methylation in response to elevated cardiac load. J. Clin. Invest. 123, 1359-1370 (2013
30. Backs, J., Song, K., Bezprozvannaya, S., Chang, S., & Olson, E. N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864 (2006
31. Vega, R. B., et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell Biol. 24, 8374-8385 (2004
32. Wu, X., et al. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-Transcription coupling. J. Clin. Invest. 116, 675-682 (2006
33. Backs, J., et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195, 403-415 (2011
34. Ha, C. H., et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA 107, 15467-15472 (2010
35. Lemon, D. D., et al. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J. Mol. Cell. Cardiol. 51, 41-50 (2011
36. Demos-Davies, K. M., et al. HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling. Am. J. Physiol. Heart Circ. Physiol. 307, H252-H258 (2014
37. Trivedi, C. M., et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat. Med. 13, 324-331 (2007
38. Montgomery, R. L., et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 118, 3588-3597 (2008
39. Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. Regulation of peroxisome proliferator-Activated receptor gamma coactivator 1 alpha (PGC 1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl Acad. Sci. USA 100, 1711-1716 (2003
40. Kong, Y., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113, 2579-2588 (2006
41. Kee, H. J., et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113, 51-59 (2006
42. Xie, M., et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129, 1139-1151 (2014
43. Gallo, P., et al. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc. Res. 80, 416-424 (2008
44. Bannister, A. J., & Kouzarides, T. Reversing histone methylation. Nature 436, 1103-1106 (2005
45. Greer, E. L., & Shi, Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357 (2012
46. Zhang, Y., & Reinberg, D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15, 2343-2360 (2001
47. Cloos, P. A., Christensen, J., Agger, K., & Helin, K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22, 1115-1140 (2008
48. Zhang, Q. J., et al. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J. Clin. Invest. 121, 2447-2456 (2011
49. Stein, A. B., et al. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J. Clin. Invest. 121, 2641-2650 (2011
50. Cattaneo, P., et al. DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation. Cell Death Differ. http://dx.doi.org/10.1038/cdd.2014.199
51. Nguyen, A. T., et al. DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev. 25, 263-274 (2011
52. Papait, R., et al. Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc. Natl Acad. Sci. USA 110, 20164-20169 (2013
53. Clapier, C. R., & Cairns, B. R. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78, 273-304 (2009
54. Mohrmann, L., & Verrijzer, C. P. Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim. Biophys. Acta 1681, 59-73 (2005
55. Bao, Y., & Shen, X. INO80 subfamily of chromatin remodeling complexes. Mutat. Res. 618, 18-29 (2007
56. Corona, D. F., & Tamkun, J. W. Multiple roles for ISWI in transcription, chromosome organization and DNA replication. Biochim. Biophys. Acta 1677, 113-119 (2004
57. Marfella, C. G., & Imbalzano, A. N. The Chd family of chromatin remodelers. Mutat. Res. 618, 30-40 (2007
58. Varga-Weisz, P. ATP-dependent chromatin remodeling factors: nucleosome shufflers with many missions. Oncogene 20, 3076-3085 (2001
59. Han, P., Hang, C. T., Yang, J., & Chang, C. P. Chromatin remodeling in cardiovascular development and physiology. Circ. Res. 108, 378-396 (2011
60. Lessard, J., et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 55, 201-215 (2007
61. Hang, C. T., et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466, 62-67 (2010
62. Mehrotra, A., Joe, B., & de la Serna, I. L. SWI/SNF chromatin remodeling enzymes are associated with cardiac hypertrophy in a genetic rat model of hypertension. J. Cell. Physiol. 228, 2337-2342 (2013
63. Musselman, C. A., Lalonde, M. E., Cote, J., & Kutateladze, T. G. Perceiving the epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 19, 1218-1227 (2012
64. Yun, M., Wu, J., Workman, J. L., & Li, B. Readers of histone modifications. Cell Res. 21, 564-578 (2011
65. Spiltoir, J. I., et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 63, 175-179 (2013
66. Anand, P., et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 154, 569-582 (2013
67. Wang, K. C., & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904-914 (2011
68. Mitra, S. A., Mitra, A. P., & Triche, T. J. A central role for long non-coding RNA in cancer. Front. Genet. 3, 17 (2012
69. Qureshi, I. A., & Mehler, M. F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 13, 528-541 (2012
70. Mattick, J. S. The genetic signatures of noncoding RNAs. PLoS Genet. 5, e1000459 (2009
71. Mattick, J. S., Amaral, P. P., Dinger, M. E., Mercer, T. R., & Mehler, M. F. RNA regulation of epigenetic processes. Bioessays 31, 51-59 (2009
72. Condorelli, G., Latronico, M. V., & Cavarretta, E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 63, 2177-2187 (2014
73. Thum, T., & Condorelli, G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 116, 751-762 (2015
74. Olson, E. N. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med. 6, 239ps3 (2014
75. Saito, Y., et al. Specific activation of microRNA 127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443 (2006
76. Chhabra, R. miRNA and methylation: a multifaceted liaison. Chembiochem 16, 195-203 (2014
77. Aavik, E., et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu437
78. Fabbri, M., et al. MicroRNA 29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104, 15805-15810 (2007
79. Garzon, R., et al MicroRNA 29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113, 6411-6418 (2009
80. Roncarati, R., et al. Circulating miR 29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 63, 920-927 (2014
81. van Rooij, E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR 29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105, 13027-13032 (2008
82. Chavali, V., Tyagi, S. C., & Mishra, P. K. MicroRNA 133a regulates DNA methylation in diabetic cardiomyocytes. Biochem. Biophys. Res. Commun. 425, 668-672 (2012
83. Care, A., et al. MicroRNA 133 controls cardiac hypertrophy. Nat. Med. 13, 613-618 (2007
84. Kwak, H., & Lis, J. T. Control of transcriptional elongation. Annu. Rev. Genet. 47, 483-508 (2013
85. Adelman, K., & Lis, J. T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13, 720-731 (2012
86. Sakurai, K., et al. MicroRNAs miR 199a 5p and-3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res. 71, 1680-1689 (2011
87. Chen, J. F., et al. The role of microRNA 1 and microRNA 133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233 (2006
88. Mathiyalagan, P., et al. The primary microRNA 208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. Nucleic Acids Res. 42, 790-803 (2014
89. Khalil, A. M., et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106, 11667-11672 (2009
90. Boheler, K. R., Chassagne, C., Martin, X., Wisnewsky, C., & Schwartz, K. Cardiac expressions of alpha-And beta-myosin heavy chains and sarcomeric alpha-Actins are regulated through transcriptional mechanisms: results from nuclear run-on assays in isolated rat cardiac nuclei. J. Biol. Chem. 267, 12979-12985 (1992
91. Klattenhoff, C. A., et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152, 570-583 (2013
92. Grote, P., et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev. Cell 24, 206-214 (2013
93. Ounzain, S., et al. Functional importance of cardiac enhancer-Associated noncoding RNAs in heart development and disease. J. Mol. Cell. Cardiol. 76, 55-70 (2014
94. Yang, K. C., et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation 129, 1009-1021 (2014
95. Matkovich, S. J., Edwards, J. R., Grossenheider, T. C., de Guzman Strong, C., & Dorn, G. W. 2nd. Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc. Natl Acad. Sci. USA 111, 12264-12269 (2014
96. Wang, K., et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR 489. Circ. Res. 114, 1377-1388 (2014
97. Ounzain, S., et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur. Heart J. 36, 353-368 (2015
98. Annilo, T., Kepp, K., & Laan, M. Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol. Biol. 10, 81 (2009
99. Voigtsberger, S., Bartsch, H., Baumann, G., & Luther, H. P. Cell type-specific expression of endogenous cardiac troponin I antisense RNA in the neonatal rat heart. Mol. Cell. Biochem. 324, 1-11 (2009
100. Ritter, O., Haase, H., Schulte, H. D., Lange, P. E., & Morano, I. Remodeling of the hypertrophied human myocardium by cardiac bHLH transcription factors. J. Cell. Biochem. 74, 551-561 (1999
101. Haddad, F., et al. Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am. J. Physiol. Heart Circ. Physiol. 294, H29-H40 (2008
102. Guttman, M., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300 (2011
103. Sati, S., Ghosh, S., Jain, V., Scaria, V., & Sengupta, S. Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci. Nucleic Acids Res. 40, 10018-10031 (2012
104. Wutz, A., Rasmussen, T. P., & Jaenisch, R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat. Genet. 30, 167-174 (2002
105. Rinn, J. L., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007
106. Mohammad, F., Mondal, T., Guseva, N., Pandey, GK., & Kanduri, C. Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1. Development 137, 2493-2499 (2010
107. Di Ruscio, A., et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 503, 371-376 (2013
108. Han, P., et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514, 102-106 (2014
109. Venter, J. C., et al. The sequence of the human genome. Science 291, 1304-1351 (2001
110. Vilar, J. M., & Saiz, L. DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise. Curr. Opin. Genet. Dev. 15, 136-144 (2005
111. Heintzman, N. D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318 (2007
112. Visel, A., et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858 (2009
113. Barski, A., et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007
114. Rada-Iglesias, A., et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011
115. Bannister, A. J., & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381-395 (2011
116. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007